Loading...
After a hiatus of 2 years in which IDWeek was virtual only, over 9000 infectious diseases experts gathered in person for this year's IDWeek meeting, held in Washington, DC, October 20 to 23, to discuss the latest research in infectious diseases. NEJM Group covered the meeting, with guidance from NEJM Journal Watch Infectious Diseases Associate Editors Rajesh Gandhi, MD, and Carlos del Rio, MD. Here are some highlights of that coverage. Abstracts are available on the IDWeek meeting site.
Ceftriaxone is associated with worse outcomes than cefazolin or antistaphylococcal penicillins for outpatient treatment of methicillin-susceptible Staphylococcus aureus (MSSA…